Concordia International Corp. Company Profile

Aggregated data from the web about Concordia International Corp.

Company Name	Concordia International Corp.
Website	concordiarx.com
Snippet	Advanz Pharma, formerly known as Concordia Healthcare Corp is a publicly traded pharmaceutical company based in Canada. It changed its name in December 2018.[2] The company focuses on Attention-Deficit Hyperactivity Disorder, cancer and asthma. The company was founded in December 2012 [3] and has since pursued a corporate strategy of growth-through acquisition, much like fellow Canadian company Valeant Pharmaceuticals. Concordia uses Cardinal Health as its main distribution chain partner. The company also focuses on acquiring legacy pharmaceutical compounds which are usually off patent.[4] Concordia Healthcare Corp currently comprises three companies: Concordia Pharmaceuticals Inc., Pinnacle Biologics Inc., and Complete Medical Homecare Inc.[5]
Type	Public company
Founded	2012
Revenue	$122 million (2014)[1]
Website	concordiarx.com
Industry	Pharmaceutical industry
Products	Kapvay, Zonegran, Donnatal
Traded as	TSX: CXR
Key people	Allan Oberman CEO)David Price (CFO)
Headquarters	Canada

Concordia International Corp. is part of the Canada company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.